HUP0402383A3 - Antibiotics ge 81112 factors a, b, b1, pharmaceutically acceptable salts and compositions, and use thereof - Google Patents
Antibiotics ge 81112 factors a, b, b1, pharmaceutically acceptable salts and compositions, and use thereofInfo
- Publication number
- HUP0402383A3 HUP0402383A3 HU0402383A HUP0402383A HUP0402383A3 HU P0402383 A3 HUP0402383 A3 HU P0402383A3 HU 0402383 A HU0402383 A HU 0402383A HU P0402383 A HUP0402383 A HU P0402383A HU P0402383 A3 HUP0402383 A3 HU P0402383A3
- Authority
- HU
- Hungary
- Prior art keywords
- antibiotics
- factors
- compositions
- pharmaceutically acceptable
- acceptable salts
- Prior art date
Links
- 239000003242 anti bacterial agent Substances 0.000 title 1
- 229940088710 antibiotic agent Drugs 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 150000003839 salts Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
- C12P1/06—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using actinomycetales
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
- C12P1/04—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Oncology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Saccharide Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Compounds Of Unknown Constitution (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP01128204 | 2001-11-28 | ||
| PCT/EP2002/011113 WO2003046192A1 (en) | 2001-11-28 | 2002-10-04 | Antibiotics ge 81112 factors a, b, b1, pharmaceutically acceptable salts and compositions, and use thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HUP0402383A2 HUP0402383A2 (hu) | 2005-02-28 |
| HUP0402383A3 true HUP0402383A3 (en) | 2008-03-28 |
Family
ID=8179366
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0402383A HUP0402383A3 (en) | 2001-11-28 | 2002-10-04 | Antibiotics ge 81112 factors a, b, b1, pharmaceutically acceptable salts and compositions, and use thereof |
Country Status (22)
| Country | Link |
|---|---|
| US (3) | US7407654B2 (hu) |
| EP (1) | EP1448784B1 (hu) |
| JP (1) | JP4452505B2 (hu) |
| KR (1) | KR20040099257A (hu) |
| CN (1) | CN1596312A (hu) |
| AT (1) | ATE390490T1 (hu) |
| AU (2) | AU2002365433A1 (hu) |
| BR (1) | BR0214494A (hu) |
| CA (1) | CA2468400A1 (hu) |
| DE (1) | DE60225834T2 (hu) |
| ES (1) | ES2299635T3 (hu) |
| HR (1) | HRP20040471A2 (hu) |
| HU (1) | HUP0402383A3 (hu) |
| IL (1) | IL161896A0 (hu) |
| MX (1) | MXPA04005032A (hu) |
| NO (1) | NO20042181L (hu) |
| NZ (1) | NZ533732A (hu) |
| PL (1) | PL370451A1 (hu) |
| RU (1) | RU2004119432A (hu) |
| WO (1) | WO2003046192A1 (hu) |
| YU (1) | YU46804A (hu) |
| ZA (1) | ZA200403675B (hu) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE390490T1 (de) * | 2001-11-28 | 2008-04-15 | Vicuron Pharm Inc | Antibiotika-ge-81112-faktoren a, b, b1, pharmazeutisch unbedenkliche salze und zusammensetzungen sowie verwendungen davon |
| US11744859B2 (en) | 2017-07-07 | 2023-09-05 | Epicentrx, Inc. | Compositions and methods for parenteral administration of therapeutic agents |
| KR102408301B1 (ko) * | 2020-03-16 | 2022-06-10 | 강원대학교산학협력단 | 항균 활성을 갖는 신균주 스트렙토마이세스 sbc-4 및 이의 용도 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5043353A (en) * | 1989-10-10 | 1991-08-27 | Eli Lilly And Company | A80789 polyether antibiotic |
| AU679202B2 (en) * | 1992-12-22 | 1997-06-26 | Gruppo Lepetit S.P.A. | Antibiotics GE 37468 A, B and C |
| US5432193A (en) * | 1993-05-14 | 1995-07-11 | American Cyanamid Company | Antibiotic LL-D37187α |
| US5426108A (en) | 1993-11-10 | 1995-06-20 | American Cyanamid Company | Antibiotic 31F508 ALPHA1, ALPHA2, BETA1 and BETA2 |
| US5486630A (en) * | 1994-09-14 | 1996-01-23 | Cheil Foods & Chemicals Inc. | Legionella specific antibiotic |
| ATE390490T1 (de) * | 2001-11-28 | 2008-04-15 | Vicuron Pharm Inc | Antibiotika-ge-81112-faktoren a, b, b1, pharmazeutisch unbedenkliche salze und zusammensetzungen sowie verwendungen davon |
-
2002
- 2002-10-04 AT AT02803759T patent/ATE390490T1/de not_active IP Right Cessation
- 2002-10-04 JP JP2003547624A patent/JP4452505B2/ja not_active Expired - Fee Related
- 2002-10-04 CN CNA02823720XA patent/CN1596312A/zh active Pending
- 2002-10-04 DE DE60225834T patent/DE60225834T2/de not_active Expired - Lifetime
- 2002-10-04 RU RU2004119432/13A patent/RU2004119432A/ru not_active Application Discontinuation
- 2002-10-04 WO PCT/EP2002/011113 patent/WO2003046192A1/en active IP Right Grant
- 2002-10-04 IL IL16189602A patent/IL161896A0/xx unknown
- 2002-10-04 MX MXPA04005032A patent/MXPA04005032A/es not_active Application Discontinuation
- 2002-10-04 AU AU2002365433A patent/AU2002365433A1/en not_active Abandoned
- 2002-10-04 EP EP02803759A patent/EP1448784B1/en not_active Expired - Lifetime
- 2002-10-04 US US10/496,009 patent/US7407654B2/en not_active Expired - Fee Related
- 2002-10-04 KR KR10-2004-7008079A patent/KR20040099257A/ko not_active Application Discontinuation
- 2002-10-04 YU YU46804A patent/YU46804A/sh unknown
- 2002-10-04 ES ES02803759T patent/ES2299635T3/es not_active Expired - Lifetime
- 2002-10-04 BR BR0214494-8A patent/BR0214494A/pt not_active IP Right Cessation
- 2002-10-04 CA CA002468400A patent/CA2468400A1/en not_active Abandoned
- 2002-10-04 NZ NZ533732A patent/NZ533732A/en unknown
- 2002-10-04 HU HU0402383A patent/HUP0402383A3/hu unknown
- 2002-10-04 PL PL02370451A patent/PL370451A1/xx not_active Application Discontinuation
-
2004
- 2004-05-13 ZA ZA200403675A patent/ZA200403675B/xx unknown
- 2004-05-26 NO NO20042181A patent/NO20042181L/no not_active Application Discontinuation
- 2004-05-27 HR HR20040471A patent/HRP20040471A2/xx not_active Application Discontinuation
-
2008
- 2008-06-26 US US12/147,215 patent/US8007789B2/en not_active Expired - Fee Related
- 2008-12-08 AU AU2008255202A patent/AU2008255202A1/en not_active Abandoned
-
2011
- 2011-08-05 US US13/198,754 patent/US20110286996A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| DE60225834D1 (de) | 2008-05-08 |
| ES2299635T3 (es) | 2008-06-01 |
| WO2003046192A1 (en) | 2003-06-05 |
| EP1448784A1 (en) | 2004-08-25 |
| US8007789B2 (en) | 2011-08-30 |
| DE60225834T2 (de) | 2009-04-09 |
| CN1596312A (zh) | 2005-03-16 |
| RU2004119432A (ru) | 2006-01-10 |
| IL161896A0 (en) | 2005-11-20 |
| US7407654B2 (en) | 2008-08-05 |
| EP1448784B1 (en) | 2008-03-26 |
| YU46804A (sh) | 2006-08-17 |
| ATE390490T1 (de) | 2008-04-15 |
| HRP20040471A2 (en) | 2004-10-31 |
| KR20040099257A (ko) | 2004-11-26 |
| HUP0402383A2 (hu) | 2005-02-28 |
| AU2008255202A1 (en) | 2009-01-08 |
| AU2002365433A1 (en) | 2003-06-10 |
| NZ533732A (en) | 2005-05-27 |
| CA2468400A1 (en) | 2003-06-05 |
| US20050020514A1 (en) | 2005-01-27 |
| US20090023665A1 (en) | 2009-01-22 |
| PL370451A1 (en) | 2005-05-30 |
| ZA200403675B (en) | 2005-05-13 |
| BR0214494A (pt) | 2004-10-19 |
| US20110286996A1 (en) | 2011-11-24 |
| JP4452505B2 (ja) | 2010-04-21 |
| MXPA04005032A (es) | 2004-08-11 |
| JP2005510573A (ja) | 2005-04-21 |
| NO20042181L (no) | 2004-08-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL213240A (en) | Pharmacy composition containing poly-fluorescein conjugate | |
| EG24357A (en) | New Pharmaceutical composition | |
| EG23943A (en) | Flash-melt oral dosage formulation | |
| IL175953A (en) | Derivatives of 3-Cycloalkylaminopyrrolidine, their Pharmaceutical Salts and Preparations Containing Them | |
| HUP0301949A3 (en) | Compounds with a sulfonamide group and pharmaceutical compositions containing these compounds | |
| HUP0102255A3 (en) | Vla-4 inhibitor omepupa-v, pharmaceutical compositions comprising thereof and their use | |
| IL159886A0 (en) | Oral antidiabetic agents | |
| TWI340167B (en) | Antibiotic 107891, its factors a1 and a2, pharmaceutically acceptable salts and compositions, and use thereof | |
| GB0105613D0 (en) | Pharmaceutically effective compounds and their use | |
| HUP0202223A3 (en) | Pseudomycin prodrugs, pharmaceutical compositions comprising thereof and their use | |
| HUP0402383A3 (en) | Antibiotics ge 81112 factors a, b, b1, pharmaceutically acceptable salts and compositions, and use thereof | |
| MXPA03007487A (es) | Composicion medicinal que comprende diclofenaco y ornoprostil. | |
| HRP20040691A2 (en) | 2'-halo-3',5'-dialkoxyphen-1'-yl-imino-2-imidazolidine and the use thereof as a drug | |
| ZA200309512B (en) | Crystalline form a phenylethanolamine, the preparation thereof and pharmaceutical compositions comprising the same. | |
| AU2001278788A1 (en) | Oral composition | |
| AU2001278487A1 (en) | Oral composition | |
| GB0013400D0 (en) | A formulation | |
| GB2384987B (en) | A head lice formulation | |
| HUP0301199A3 (en) | A dioxo-thiazolidinedione and its use as antidiabetic | |
| AU2002212109A1 (en) | 1,3-diazaheterocyclic compounds and their use as oral hypoglycaemic agents | |
| AU143476S (en) | A football | |
| AUPQ875300A0 (en) | A pharmaceutical composition | |
| AU2002331221A1 (en) | Composition comprising paroxetine and a pharmaceutically acceptable glycyrrhizinate salt | |
| AUPR417801A0 (en) | Med count 1 | |
| AUPR417901A0 (en) | Med count 2 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD9A | Lapse of provisional protection due to non-payment of fees |